FIELD: chemistry.
SUBSTANCE: method is realised by forming an oligopeptide having neuregulin-1 activity on cardiomyocyte proliferation, said oligopeptide having general formula: X1-X2-X3-X4-X5-X6-X7, where X1 is K, X2 is G or A, X3 is A or is absent, X4 is M, X5 is G or A, X6 is A or is absent, X7 is K, where the size of the oligopeptide varies from penta to heptapeptide.
EFFECT: obtaining a synthetic analogue of neuregulin-1 growth factor, capable of stimulating cardiomyocyte proliferation as a result of binding with receptors on the surface of stem cells.
2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OLIGOPEPTIDE HAVING TRANSFORMATION GROWTH FACTOR (TGF-β) AND ONCOSTATIN M (OSM) TOWARDS FIBROBLAST PROLIFERATION | 2008 |
|
RU2385874C2 |
| OLIGOPEPTIDE WITH ACTIVITY OF VASCULAR ENDOTHELIUM GROWTH FACTOR (VEGF) WITH RESPECT TO ANGIOGENESIS STIMULATION | 2008 |
|
RU2375373C1 |
| PEPTIDE SHOWING GROWTH STIMULATING ACTIVITY OF HEPATOCYTE GROWTH FACTOR (HGF) | 2009 |
|
RU2426740C1 |
| OLIGOPEPTIDE WITH STEM CELL FACTOR CSF ACTIVITY TOWARDS THYMOCYTE DIFFERENTIATION | 2008 |
|
RU2374262C1 |
| OLIGOPEPTIDE HAVING CARTILAGE-DERIVED MORPHOGENETIC PROTEIN (CDMP-1) ACTIVITY ON CHONDROCYTE PROLIFERATION | 2009 |
|
RU2408603C1 |
| METHOD OF PREDICTING EFFICIENCY OF CHEMOTHERAPY IN TREATMENT OF MAMMARY GLAND CANCER | 2014 |
|
RU2551232C1 |
| OLIGOPEPTIDE HAVING ACIDIC (aFGF) AND TRANSFORMING (TGF-β) GROWTH FACTOR ACTIVITY TOWARDS STIMULATION OF COLLAGEN BIOSYNTHESIS | 2008 |
|
RU2385873C2 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING DISTANT METASTASES IN PATIENTS WITH OPERABLE FORMS OF BREAST CANCER WITH METASTASES IN REGIONAL LYMPH NODES | 2020 |
|
RU2733697C1 |
| CYCLIC ANALOGUES OF GALANIN AND METHOD OF THEIR APPLICATION | 2016 |
|
RU2727013C2 |
| PEPTIDE HAVING GROWTH-STIMULATING FACTOR OF HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR | 2008 |
|
RU2385875C2 |
